AVAC: Global Advocacy for HIV Prevention - Advocates' Network Update
 
July 1, 2010

Dear Advocates,

We are pleased to announce the release of this quarter's issue of Px Wire, AVAC's update on biomedical prevention research worldwide. Download the current issue here (July-September 2010 Volume 3, Number 3).

In this issue you'll find a brief review of highlights from the biannual International Microbicides Conference (M2010) held in May, including discussions of the potential opportunities and challenges of ARV-based prevention in topical and oral forms, new developments in delivery systems for microbicides and increasing recognition of rectal microbicides as a key area for exploration.

Also covered in this issue is what to expect in July at the XVIII International AIDS Conference in Vienna, which will include a wide range of sessions central to the field, including the of results from the CAPRISA 004 trial--the first effectiveness trial of an ARV-based microbicide. See the Not to be Missed section for details on this and other important conference events. And, go to www.avac.org/AIDS2010 for a roadmap to HIV prevention research symposiums, sessions and satellites at the conference.

As usual, this issue includes an up-to-date comprehensive prevention research map and a timeline of large-scale biomedical HIV prevention trials worldwide.  

Additional resources including the Px Wire archive, information about subscribing, reprint requests and bulk orders can be found at www.avac.org/pxwire.   

Best,
AVAC
Advocacy to accelerate ethical research and global delivery of AIDS vaccines and other HIV prevention options
Follow AVAC Facebook  Twitter
423 West 127th St
4th Floor
New York, NY 10027
USA
T   +1 212 796 6423
F   +1 646 365 3452
E   avac@avac.org
W   www.avac.org
This email was sent to [EMAIL]. To ensure that you continue receiving our emails, please add us to your address book or safe list.

Got this as a forward? Sign up to receive our future emails.
If you would like to unsubscribe, email us.